Oral Corticosteroids in Costochondritis
Yes, oral corticosteroids have a clear role in costochondritis, particularly in Tietze syndrome (costochondritis with joint swelling), where a short 3-week tapering course provides significant pain relief and quality of life improvement superior to NSAIDs alone.
Evidence-Based Recommendation
The strongest evidence comes from a 2022 randomized controlled trial 1 demonstrating that adding oral prednisolone to NSAID therapy produces superior outcomes compared to NSAIDs alone:
Treatment Protocol:
- Week 1: Prednisolone 40 mg daily
- Week 2: Prednisolone 20 mg daily
- Week 3: Prednisolone 10 mg daily
- All with concurrent NSAID therapy
Clinical Outcomes
The steroid group showed significantly greater pain reduction at all time points 1:
- Week 1: 46.8% vs 17.7% pain reduction (p < 0.001)
- Week 2: 56.3% vs 35.8% pain reduction (p < 0.001)
- Week 3: 65.4% vs 46.7% pain reduction (p < 0.001)
- 6.5 months post-treatment: 25.8% sustained difference in pain scores favoring steroids
Quality of life improved significantly more with steroids (median EQ-5D-5L score 7 vs 10, p < 0.001) 1.
Clinical Algorithm
Step 1: Confirm Diagnosis
- Focal tenderness at costochondral junction (typically 2nd-5th ribs)
- Presence or absence of visible/palpable swelling (Tietze syndrome if present)
- Rule out cardiac, pulmonary, or infectious causes
Step 2: Initial Treatment Selection
- If significant pain/functional impairment: Start 3-week oral corticosteroid taper PLUS NSAIDs
- If mild symptoms: Trial NSAIDs alone for 1-2 weeks first
Step 3: Refractory Cases
- Consider ultrasound-guided corticosteroid injection directly into affected costochondral joint 2
- Typical dose: equivalent to what's used for other joint injections (not specifically defined for costochondritis, but extrapolating from joint injection principles)
Important Caveats
Exclude infectious costochondritis first - this is critical. Infectious costochondritis requires antibiotics and possibly surgical debridement, NOT steroids 3. Red flags include:
- Fever, systemic symptoms
- Purulent drainage or skin changes
- Diabetes or immunocompromised state
- Recent thoracic surgery or trauma
- Failure to improve with initial treatment
Avoid long-term corticosteroid use - the evidence supports only short courses. Guidelines for chronic inflammatory conditions explicitly warn against prolonged glucocorticoid therapy due to cardiovascular and osteoporotic risks 4, 5.
Nuances in the Evidence
While a 2012 systematic review found insufficient evidence for corticosteroids in costochondritis 6, the 2022 RCT 1 provides the definitive answer with Level 1 evidence. The trial specifically addressed Tietze syndrome, but the mechanism (reducing inflammation at the costochondral junction) applies to costochondritis generally.
The key distinction: Joint swelling resolution did not correlate with pain improvement (only 10% vs 5% had visible swelling reduction) 1, suggesting steroids work primarily through pain modulation and inflammation reduction rather than structural changes.
Ultrasound-guided injection offers an alternative route when oral therapy fails, with case reports showing complete resolution after 3 injections 2, though this lacks RCT validation.